{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T16:50:24Z","timestamp":1773939024785,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","liver.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.cld.2015.04.005","type":"journal-article","created":{"date-parts":[[2015,5,30]],"date-time":"2015-05-30T12:47:10Z","timestamp":1432990030000},"page":"551-563","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Treatment of Overt Hepatic Encephalopathy"],"prefix":"10.1016","volume":"19","author":[{"given":"Norman L.","family":"Sussman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cld.2015.04.005_bib1","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.cgh.2012.05.016","article-title":"In-hospital mortality and economic burden associated with hepatic encephalopathy in the United States from 2005 to 2009","volume":"10","author":"Stepanova","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2015.04.005_bib2","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1002\/lt.23981","article-title":"Hepatic encephalopathy is associated with significantly increased mortality among patients awaiting liver transplantation","volume":"20","author":"Wong","year":"2014","journal-title":"Liver Transpl"},{"key":"10.1016\/j.cld.2015.04.005_bib3","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/hep.25995","article-title":"Hepatic encephalopathy is associated with decreased cerebral oxygen metabolism and blood flow, not increased ammonia uptake","volume":"57","author":"Dam","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.04.005_bib4","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1478-3231.2009.02009.x","article-title":"Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines","volume":"29","author":"Randolph","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2015.04.005_bib5","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1002\/hep.23216","article-title":"Spectrum of neurocognitive impairment in cirrhosis: implications for the assessment of hepatic encephalopathy","volume":"50","author":"Bajaj","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.04.005_bib6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.medici.2014.06.008","article-title":"Concise review of current concepts on nomenclature and pathophysiology of hepatic encephalopathy","volume":"50","author":"Savlan","year":"2014","journal-title":"Medicina"},{"key":"10.1016\/j.cld.2015.04.005_bib7","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hep.27210","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver","volume":"60","author":"Vilstrup","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.04.005_bib8","doi-asserted-by":"crossref","first-page":"5442","DOI":"10.3748\/wjg.v20.i18.5442","article-title":"Cirrhosis and its complications: evidence based treatment","volume":"20","author":"Nusrat","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cld.2015.04.005_bib9","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1177\/2050640614560452","article-title":"Managing complications in cirrhotic patients","volume":"3","author":"Peck-Radosavljevic","year":"2015","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.cld.2015.04.005_bib10","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/hep.20095","article-title":"Minimal hepatic encephalopathy impairs fitness to drive","volume":"39","author":"Wein","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.04.005_bib11","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s10620-011-1888-3","article-title":"Driving simulation can improve insight into impaired driving skills in cirrhosis","volume":"57","author":"Bajaj","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cld.2015.04.005_bib12","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/hep.25507","article-title":"Diagnosis and treatment of minimal hepatic encephalopathy to prevent motor vehicle accidents: a cost-effectiveness analysis","volume":"55","author":"Bajaj","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.04.005_bib13","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.cgh.2010.08.002","article-title":"Legal ramifications for physicians of patients who drive with hepatic encephalopathy","volume":"9","author":"Cohen","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2015.04.005_bib14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jemermed.2005.04.015","article-title":"Physician reporting of medically impaired drivers","volume":"30","author":"Aschkenasy","year":"2006","journal-title":"J\u00a0Emerg Med"},{"key":"10.1016\/j.cld.2015.04.005_bib15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-230X-8-16","article-title":"Liver cirrhosis, other liver diseases, and risk of hospitalisation for intracerebral haemorrhage: a Danish population-based case-control study","volume":"8","author":"Gronbaek","year":"2008","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.cld.2015.04.005_bib16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cgh.2014.05.022","article-title":"Low likelihood of intracranial hemorrhage in patients with cirrhosis and altered mental status","volume":"13","author":"Donovan","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2015.04.005_bib17","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/0884533610368712","article-title":"Nutrition in hepatic encephalopathy","volume":"25","author":"Chadalavada","year":"2010","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.cld.2015.04.005_bib18","first-page":"489823","article-title":"Role of nutrition in the management of hepatic encephalopathy in end-stage liver failure","volume":"2010","author":"Bemeur","year":"2010","journal-title":"J\u00a0Nutr Metab"},{"key":"10.1016\/j.cld.2015.04.005_bib19","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.nut.2013.01.022","article-title":"Branched-chain amino acids and ammonia metabolism in liver disease: therapeutic implications","volume":"29","author":"Holecek","year":"2013","journal-title":"Nutrition"},{"key":"10.1016\/j.cld.2015.04.005_bib20","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/bmj.299.6709.1202","article-title":"Effect of a late evening meal on nitrogen balance in patients with cirrhosis of the liver","volume":"299","author":"Swart","year":"1989","journal-title":"BMJ"},{"key":"10.1016\/j.cld.2015.04.005_bib21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.nut.2014.03.016","article-title":"Ammonia and amino acid profiles in liver cirrhosis: effects of variables leading to hepatic encephalopathy","volume":"31","author":"Holecek","year":"2015","journal-title":"Nutrition"},{"key":"10.1016\/j.cld.2015.04.005_bib22","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1440-1746.2011.06951.x","article-title":"Late evening snack: exploiting a period of anabolic opportunity in cirrhosis","volume":"27","author":"Tsien","year":"2012","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2015.04.005_bib23","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.bbrc.2003.11.023","article-title":"Pharmacological activities of branched-chain amino acids: specificity of tissue and signal transduction","volume":"313","author":"Nishitani","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.cld.2015.04.005_bib24","first-page":"1263","article-title":"Oral branched-chain amino acids have a beneficial effect on manifestations of hepatic encephalopathy in a systematic review with meta-analyses of randomized controlled trials","volume":"143","author":"Gluud","year":"2013","journal-title":"J\u00a0Nutr"},{"issue":"2","key":"10.1016\/j.cld.2015.04.005_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003044.pub2","article-title":"Nonabsorbable disaccharides for hepatic encephalopathy","author":"Als-Nielsen","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cld.2015.04.005_bib26","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/MEG.0b013e3283341b7d","article-title":"Predictors of nonresponse to lactulose in patients with cirrhosis and hepatic encephalopathy","volume":"22","author":"Sharma","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2015.04.005_bib27","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/j.1440-1746.2012.07186.x","article-title":"Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose","volume":"27","author":"Sharma","year":"2012","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2015.04.005_bib28","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jhep.2014.09.005","article-title":"Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute on chronic liver failure","volume":"62","author":"Romero-Gomez","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2015.04.005_bib29","doi-asserted-by":"crossref","first-page":"397","DOI":"10.4161\/gmic.28684","article-title":"The role of microbiota in hepatic encephalopathy","volume":"5","author":"Bajaj","year":"2014","journal-title":"Gut Microbes"},{"key":"10.1016\/j.cld.2015.04.005_bib30","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1001\/jamainternmed.2014.4746","article-title":"Lactulose vs polyethylene glycol 3350-electrolyte solution for treatment of overt hepatic encephalopathy: the help randomized clinical trial","volume":"174","author":"Rahimi","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cld.2015.04.005_bib31","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/j.1365-2036.2010.04257.x","article-title":"Predictors of the recurrence of hepatic encephalopathy in lactulose-treated patients","volume":"31","author":"Bajaj","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2015.04.005_bib32","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1053\/j.gastro.2009.05.056","article-title":"Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo","volume":"137","author":"Sharma","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2015.04.005_bib33","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/ajg.2012.113","article-title":"Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy","volume":"107","author":"Agrawal","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2015.04.005_bib34","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11011-013-9383-5","article-title":"Antibiotics for the treatment of hepatic encephalopathy","volume":"28","author":"Patidar","year":"2013","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.cld.2015.04.005_bib35","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1097\/MEG.0b013e328302f470","article-title":"Rifaximin versus nonabsorbable disaccharides in the management of hepatic encephalopathy: a meta-analysis","volume":"20","author":"Jiang","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2015.04.005_bib36","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMoa0907893","article-title":"Rifaximin treatment in hepatic encephalopathy","volume":"362","author":"Bass","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2015.04.005_bib37","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/ajg.2013.219","article-title":"A\u00a0randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy","volume":"108","author":"Sharma","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2015.04.005_bib38","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.cgh.2013.12.021","article-title":"Rifaximin is safe and well tolerated for long-term maintenance of remission from overt hepatic encephalopathy","volume":"12","author":"Mullen","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2015.04.005_bib39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/apt.12993","article-title":"Prolonged remission from hepatic encephalopathy with rifaximin: results of a placebo crossover analysis","volume":"41","author":"Bajaj","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2015.04.005_bib40","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.cgh.2013.11.006","article-title":"Probiotics prevent hepatic encephalopathy in patients with cirrhosis: a randomized controlled trial","volume":"12","author":"Lunia","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2015.04.005_bib41","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1053\/j.gastro.2014.08.031","article-title":"Probiotic VSL#3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial","volume":"147","author":"Dhiman","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2015.04.005_bib42","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1475-2891-12-74","article-title":"A\u00a0systematic review and meta-analysis of the use of oral zinc in the treatment of hepatic encephalopathy","volume":"12","author":"Chavez-Tapia","year":"2013","journal-title":"Nutr J"},{"key":"10.1016\/j.cld.2015.04.005_bib43","first-page":"219","article-title":"Sodium benzoate for treatment of hepatic encephalopathy","volume":"9","author":"Misel","year":"2013","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"10.1016\/j.cld.2015.04.005_bib44","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1002\/hep.23589","article-title":"Pharmacology and safety of glycerol phenylbutyrate in healthy adults and adults with cirrhosis","volume":"51","author":"McGuire","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.04.005_bib45","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/hep.26611","article-title":"Randomized, double-blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathy","volume":"59","author":"Rockey","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2015.04.005_bib46","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1097\/MCG.0b013e318299c789","article-title":"Safety of ornithine phenylacetate in cirrhotic decompensated patients: an open-label, dose-escalating, single-cohort study","volume":"47","author":"Ventura-Cots","year":"2013","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cld.2015.04.005_bib47","first-page":"105","article-title":"Treatment of hyperammonemia in liver failure","volume":"17","author":"Jover-Cobos","year":"2014","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.cld.2015.04.005_bib48","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/jgh.12142","article-title":"l-Ornithine-l-aspartate for hepatic encephalopathy in\u00a0patients with cirrhosis: a meta-analysis of randomized controlled trials","volume":"28","author":"Bai","year":"2013","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2015.04.005_bib49","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/hepr.12235","article-title":"Oral l-ornithine-l-aspartate in\u00a0minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled trial","volume":"44","author":"Alvares-da-Silva","year":"2014","journal-title":"Hepatol Res"},{"key":"10.1016\/j.cld.2015.04.005_bib50","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S1051-0443(95)71212-X","article-title":"Successful reversal of hepatic encephalopathy with intentional occlusion of transjugular intrahepatic portosystemic shunts","volume":"6","author":"Kerlan","year":"1995","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.cld.2015.04.005_bib51","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jvir.2012.05.046","article-title":"Efficacy of balloon-occluded retrograde transvenous obliteration of large spontaneous lienorenal shunt in patients with severe recurrent hepatic encephalopathy with foam sclerotherapy: initial experience","volume":"23","author":"Mukund","year":"2012","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.cld.2015.04.005_bib52","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1111\/apt.12771","article-title":"Improvement in survival associated with embolisation of spontaneous portosystemic shunt in patients with recurrent hepatic encephalopathy","volume":"39","author":"An","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cld.2015.04.005_bib53","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/MCC.0b013e328344b3aa","article-title":"Acute-on-chronic liver failure: extracorporeal liver assist devices","volume":"17","author":"Hassanein","year":"2011","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.cld.2015.04.005_bib54","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.cgh.2014.06.002","article-title":"Artificial liver","volume":"12","author":"Sussman","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2015.04.005_bib55","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/hep.26185","article-title":"Extracorporeal albumin dialysis with the\u00a0molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial","volume":"57","author":"Banares","year":"2013","journal-title":"Hepatology"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326115000379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326115000379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T05:05:48Z","timestamp":1748408748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326115000379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S1089326115000379"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2015.04.005","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Overt Hepatic Encephalopathy","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2015.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}